Filing Details
- Accession Number:
- 0000899243-21-019762
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-18 16:45:25
- Reporting Period:
- 2021-05-14
- Accepted Time:
- 2021-05-18 16:45:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1816736 | Gemini Therapeutics Inc. | GMTX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1709008 | Patrick Jason Meyenburg | C/O Gemini Therapeutics, Inc. 300 One Kendall Square, 3Rd Floor Cambridge MA 02139 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-05-14 | 13,000 | $9.46 | 13,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
